ACTH Resistance

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients
Status:
Completed
Last Changed:
May 3, 2018
First Changed:
Jul 1, 2011
Disease(s):
Proteinuria
Intervention(s):
Repository Corticotropin InjectionPlacebo
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS
Status:
Recruiting
Last Changed:
Aug 3, 2018
First Changed:
Dec 17, 2015
Disease(s):
Idiopathic Focal Segmental Glomerulosclerosis
Intervention(s):
Acthar 80 U 2x/weekPlacebo 80 U 2x/weekActhar 80 U 3x/week
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Status:
Completed
Last Changed:
Apr 24, 2014
First Changed:
May 24, 2010
Disease(s):
Treatment Resistant Nephrotic Syndrome
Intervention(s):
ACTHAR gel

Connect. Empower. Inspire.